Monument Therapeutics

About Monument Therapeutics

Monument Tx is a UK-based clinical-stage biotech company focused on bringing precision medicine to neuroscience drug development. They use digital biomarkers to develop targeted treatments for high unmet needs in psychiatry and neurology, aiming to match the right patients to the right drugs.

Products & Services

Clinical Stage Pipeline:Includes two core treatments targeting cognitive impairment associated with schizophrenia and neuroinflammation, using proprietary digital biomarkers and novel formulations of CNS-active small molecules for accelerated clinical development.

Specialties

Precision Medicine Digital Biomarkers Psychiatry Treatments Neurology Treatments Drug Development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity T: - FT: Equity	A: 1300000 MR: - FA: £1M FAN: 1300000	D: 2024-10-15 FD: 2024-10-15	1 investors

Equity Latest

2024-10-15

$1.3M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jenny Barnett

Co-Founder, Chief Executive Officer

K

Kiri Granger

Co-Founder, Chief Scientific Officer

S

Sheryl Caswell

Co-Founder, Chief Development Officer

R

Robert Radie

Chair

R

Richard Bungay

Non-Exec Director

D

David Ford

Investor Director

View 14 more team members with Pro

Unlock Full Team Directory

Recent News